AzTrials
AzTrials

Gestational Diabetes MellitusGDMNCT01637727

Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women

An observational study of Gestational Diabetes Mellitus, run by Shaare Zedek Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary goal of this proposed research deals with estimating the risk of developing type 2 diabetes and metabolic syndrome in women with a history of GDM compared to women without a history of GDM. Read more about this study

Who is it for?
Ages 20 to 45 years, women only
Conditions the study is for
Gestational Diabetes Mellitus
How many people
324 participants
Where
1 siteIsrael
Study dates
Sep 2012to Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: The proposed research format is: a case control study using a historical cohort of women diagnosed with GDM. The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010. Women with a GDM history will be identified based on the gestational diabetes clinic files. Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records

Who may be able to join

  • The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010.
  • Women with a GDM history will be identified based on the gestational diabetes clinic files.
  • Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records

Who cannot join

  • We established the following exclusion criteria:
  • women who are diagnosed with metabolic syndrome before pregnancy or have type 1 or type 2 diabetes, and
  • women with severe chronic diseases.

Trial locations and contacts

1 site in 1 country.

SORINA GRISARO GRANOVSKY, DR contact

054-4385480

granovs@012.net.il

Israel1 site
  • Shaare Zedek Medical Center

    Jerusalem, Israel

    ORIT LAMM, MD

Other trials in Israel

About this study

The primary goal of this proposed research deals with estimating the risk of developing type 2 diabetes and metabolic syndrome in women with a history of GDM compared to women without a history of GDM. In addition, this study will attempt to evaluate the effect of parity on the late appearance of type 2 diabetes and metabolic syndrome in this unique population.

Keywords
Long term effects of gestational diabetes mellitus in a population of parous women, Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
Medical subject headings
Diabetes, Gestational

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01637727
Study groupRoleWhat they receive
GDM1The study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010. Women with a GDM history will be identified based on the gestational diabetes clinic files. Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records.
GDMThe study group will include women who gave birth in Shaare Zedek Medical Center between the years 2000 and 2010. Women with a GDM history will be identified based on the gestational diabetes clinic files. Women without a history of GDM who will be the control group will be identified from the Shaare Zedek Medical Center birth registration records.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Long term effects of gestational diabetes mellitus in a population of parous women

    The primary goal of this proposed research deals with estimating the risk of developing type 2 diabetes and metabolic syndrome in women with a history of GDM compared to women without a history of GDM

    Measured: 24-32 months

Secondary outcomes (1)
  1. Long term effects of gestational diabetes mellitus in a population of parous women

    In addition, this study will attempt to evaluate the effect of parity on the late appearance of type 2 diabetes and metabolic syndrome in this unique population.

    Measured: 24-32 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2012 (estimated)
  2. Study startSep 2012
  3. Primary completionSep 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
324 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01637727
Sponsor's protocol ID
GDM.CTIL
Other IDs
GDM.CTIL, GDMLTE.10
Acronym
GDM
Status last verified
Jul 2012
First submitted
24 Jun 2012
Last updated
13 Jul 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gestational Diabetes Mellitus, run by Shaare Zedek Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact SORINA GRISARO GRANOVSKY, DR (054-4385480, granovs@012.net.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Long term effects of gestational diabetes mellitus in a population of parous women (time frame: 24-32 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in